1-4 of 4
Evelin Hennig
Close
Sort by
Journal Articles

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Haifa K. Al-Ali, MD, Jeanett Edelmann, MD, Sabine Leiblein, PhD, Christel Mueller, Evelin Hennig, Martina Bless, Christina Franke, Dietger W. Niederwieser, MD
Journal: Blood
Blood (2005) 106 (11): 3286.
https://doi.org/10.1182/blood.V106.11.3286.3286
Published: 2005
Journal Articles

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions

Clinical Trials & Observations
Brian J. P. Huntly, Francois Guilhot, Alistair G. Reid, George Vassiliou, Evelin Hennig, Christina Franke, Jennie Byrne, Andre Brizard, Dietger Niederwieser, Julie Freeman-Edward, Gavin Cuthbert, Nick Bown, Richard E. Clark, Elizabeth P Nacheva, Anthony R Green, Michael W. N. Deininger
Journal: Blood
Blood (2003) 102 (6): 2205–2212.
https://doi.org/10.1182/blood-2002-09-2763
Published: 2003
Journal Articles

Emergence of clonal cytogenetic abnormalities in Ph − cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

Thomas Bumm, Christel Müller, Haifa-Kathrin Al-Ali, Knut Krohn, Patricia Shepherd, Erika Schmidt, Sabine Leiblein, Christina Franke, Evelin Hennig, Thomas Friedrich, Reiner Krahl, Dietger Niederwieser, Michael W. N. Deininger
Journal: Blood
Blood (2003) 101 (5): 1941–1949.
https://doi.org/10.1182/blood-2002-07-2053
Published: 2003
Journal Articles

CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall

Haifa-Kathria Al-Ali, Sabine Leiblein, Ines Kovacs, Evelin Hennig, Dietger Niederwieser, Michael W. N. Deininger
Journal: Blood
Blood (2002) 100 (3): 1092–1093.
https://doi.org/10.1182/blood-2002-03-0930
Published: 2002